Tuttle Capital Short Innovation ETF Launches on Nasdaq
The Tuttle Capital Short Innovation ETF (Nasdaq: SARK) has begun trading on the Nasdaq, providing investors with the opportunity to profit from a decline in disruptive companies, including those in electric vehicles and genomics. This actively managed ETF seeks to achieve -1x the return of the ARK Innovation ETF (NYSE Arca: ARKK) for a single day. CEO Matthew Tuttle indicates that investors are cautious about high valuations in unprofitable sectors. SARK offers one-ticker access for investors seeking to hedge against high-growth stocks.
- SARK provides a unique opportunity for investors to profit from a downturn in disruptive sectors.
- The ETF offers convenient one-ticker access for shorting strategic sectors, which could attract a diverse investor base.
- Active management of the fund could lead to more dynamic responses to market conditions.
- Investors face risks associated with inverse instruments which may not always perform as expected.
- Potential loss of principal is highlighted, emphasizing the investment risks involved.
Fund Offers Inverse Exposure to a Portfolio of Disruptive Companies
SARK offers investors of all sizes and types convenient “one-ticker” access to a short vehicle that may otherwise be difficult to execute on their own. SARK is an actively managed exchange traded fund that attempts to achieve the inverse (-1x) of the return of the ARK Innovation ETF (NYSE Arca: ARKK) for a single day, not for any other period.
“Many investors with whom we speak, including financial advisors, are cautious on current valuations for unprofitable innovative companies,” says
For more information, please visit SARKetf.com
About
TCM is an industry leader in offering thematic ETFs that utilize informed agility to manage portfolios in a more dynamic manner. Its current flagship product is The SPAC and New Issue ETF (NYSE Arca: SPCX), the first actively-managed ETF focused on pre-deal Special Purpose Acquisition Companies (SPACs). As of
The Tuttle Capital Short Innovation ETF, the Collaborative Investment Series trust, and
There is no guarantee that this, or any investment strategy will succeed. Shares of these ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. Brokerage commissions will reduce returns.
Investors should carefully consider the investment objectives, risks, charges and expenses of the Tuttle Capital Short Innovation ETF. This and other important information about the Fund are contained in the prospectus, which can be obtained SARKetf.com or by calling 866-904-0406. The prospectus should be read carefully before investing.
Investing involves risk, including the potential loss of principal.
The use of inverse instruments may expose the Fund to additional risks that it would not be subject to if it invested only in "long" positions.
Trading derivative instruments involves risks different from, or possibly greater than, the risks associated with investing directly in securities.
Distributor:
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005657/en/
Media:
Gregory
(610) 228-2140
morgan@gergoryfca.com
Source:
FAQ
What does the Tuttle Capital Short Innovation ETF (SARK) do?
Why is SARK a good investment option?
When did SARK start trading on the Nasdaq?
What are the risks associated with investing in SARK?